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Abstract
BACKGROUND: Extensive study has found depression in heart failure (HF) patients to be a
significant risk factor which has been associated with poor outcomes and increased medical cost
for this population. It is highly recommended to screen HF patients for depression to identify
this important risk factor. The PHQ-9 depression screening instrument (sensitivity 70%
specificity 92%) has been identified as a valid measure to detect depression in the HF population.
Implementing a depression screening protocol in an inpatient environment requires education of
providers to establish awareness of best practice and foster confidence in their application of the
screening instrument. OBJECTIVE: To determine if a correlation exists between provider
knowledge of depression screening in the HF population, and adherence to a depression
screening protocol. METHODS: A literature review was conducted to determine appropriate
depression screening instruments for use in the HF population. Results were utilized to develop
an education plan with pre-posttest, and depression screening protocol for implementation. A
pilot study was conducted in the critical care unit of Norton Brownsboro Hospital (NBH) from
September 27, 2017 through October 30, 2017. RESULTS: Adherence to the screening protocol
was 40.6 percent. Pre-post assessment of provider knowledge following provider education was
correct and unchanged for three out of four knowledge items. Significant (P<.05) increase of
knowledge (P= .002) for the remaining item. Perceptions of the burden of untreated/undetected
depression in the HF population increased significantly (P= .001, P= .04, P= .09).
CONCLUSIONS: No association between knowledge and adherence to a depression screening
protocol was found. Provider knowledge showed significant increase after an education
intervention. These results indicate that more is required beyond effective education of providers
to achieve the goal of depression screening in the inpatient HF population.

2

Background
Heart failure (HF) is a life-threatening condition where the heart can no longer pump
blood effectively to the body. HF is a chronic disease that effects 5.7 million people in the U.S.,
it is a contributing cause to one out of every nine deaths annually in the U.S.; an estimated 2040% of people with a diagnosis of heart failure have depression as a comorbidity (Mbakwen,
Aina, & Amadi, 2016). Heart disease is the leading cause of disability in the U.S. (CDC, 2011).
Depression is prevalent in populations with chronic diseases; more specifically depression has
been found to be independently associated with poor outcomes, specifically risk of readmission,
in the elderly heart failure population (Freedland et al., 2016). In chronically ill patients, selfefficacy is identified as being one of the strongest predictors of health-promoting behaviors and
is influenced by factors such as social support and depression (Maeda, Shen, Schwarz, Farrell, &
Mallon, 2013). Physiologic factors of depression such as lethargy and motor retardation along
with psychological factors such as pessimism and low self-esteem contribute to poor selfefficacy behavior in HF patients with comorbid depression leading to nonadherence to HF
management and consequential rehospitalization (Maeda et al., 2013).
Both prevalence and cost of care for HF in the U.S. are expected to increase greatly due
to the aging population; it is estimated that by 2030 more than 8 million Americans will have HF
with total costs increasing from $31 billion, in 2012, to $70 billion by the year 2030
(Heidenreich et al., 2013). Similarly, in 2016, the American Heart Association (AHA)
commissioned a study to project the burden of cardiovascular disease through the year 2035
(AHA, 2017). The report prepared by RTI International projects an estimated 8.8 million
Americans with HF by the year 2035 and a rise in total cost from $29 billion, in 2015, to $64
billion by 2035 (Khavjou, Phelps, & Leib, 2016).
3

Prior to recent updates, HF guidelines in the U.S. were adopted, in part, from the Scottish
Intercollegiate Guidelines Network (SIGN) HF guidelines that were published in 2007, these
guidelines do not specify depression screening as a necessary measure (SIGN, 2007). Since that
time, SIGN has updated their guidelines to include depression screening in the management of
HF, however, they do not recommend a single preferred screening instrument or treatment
approach once depression has been identified (SIGN, 2016). In April 2017, a focused update of
HF management guidelines was published by the American College of Cardiology (ACC), the
AHA Task Force on Clinical Practice Guidelines, and the Heart Failure Society of America
(HFSA). This update also fails to include depression screening as a necessary measure in the
management of HF (Yancy et al., 2017). The US Preventive Services Task Force (USPSTF) has
issued recommendations to screen all adult patients for depression, stating that the harm in doing
so is “small to none” (Sui, 2016). HF patients with depression should be comprehensively
identified due to their increased risk for poor outcomes (Rustad, Stern, Hebert, & Musselman,
2013).
Screening Instruments
To choose an appropriate depression screening instrument for use in the HF population, a
literature review was completed. A search of current evidence was done utilizing Medline,
PubMed, Ebscohost, and CINAHL databases using the terms: depression, heart failure,
depression screening, depression screening instruments, comorbid depression, readmission, and
rehospitalization. Results were limited to publications within the past 10 years, English language,
and age 18+.
A total of 9 studies met criteria for review. Rapid appraisal tools were used to verify the
quality of chosen studies and each were found to be reasonable choices for inclusion. This was
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determined by evaluating conflicts of interest and statistical evidence, specifically validity and
reliability of instruments. Strength and quality of the 9 chosen pieces of evidence are as follows:
III-A (4), III-B (2), IV-A (2), IV-B; evidence was evaluated using the Johns Hopkins rating
scheme (Newhouse et al., 2005).
The literature review provided evidence that dimensional screening instruments (BDI,
GDS, HADS, CES-D, DMI-10/18, Zung Depression Scale, Hospital Anxiety and Depression
Index, PHQ-2, PROMIS, Medical Outcome Survey-Depression Instrument) detect higher rates
of depressive symptoms where categoric instruments (DIS, CDS) rely on the precision of the
interviewer to be reliable (Johansson, Dahlstrom, & Brostrom, 2006). The challenge in choosing
a screening instrument for this population is compounded by overlapping symptoms such as
fatigue and loss of appetite which could be attributed to either depression or HF. The evidence
revealed that the GDS, BDI, CES-D, HADI, Medical Outcome Survey-Depression Instrument,
and Zung Depression Scale are all poor instruments for detecting overlap of somatic depressive
symptoms and physical cardiac symptoms (Delville & Mcdougall, 2008; Haworth, Moniz-Cook,
Clark, Wang, & Cleland, 2007; Johnson et al.,2012).
With the goal of applying use of the chosen instrument in the inpatient setting, ease of
use is also a factor to examine. The DIS and CDS are instruments that are highly valid and
reliable however they each require dedicated time and precision for accuracy and would
therefore be inappropriate for bedside use by staff nurses (Delville & Mcdougall, 2008; Haworth
et al., 2007; Ski, Thompson, Hare, Stewart, & Watson, 2012). The remaining evaluated
instruments, PROMIS- Depression Short Form, PHQ-2, HADS, DMI 10/18 and PHQ-9, vary in
length and have proved to be valid and reliable (Fischer et al., 2013; Hammash et al., 2012;
Hilton et al., 2006; Smith, 2010). Of those instruments the PHQ-9 is selected for its ease of use,
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in both the outpatient and inpatient setting, and proven ability to detect depression in the adult
HF population.
The PHQ-9 depression screening instrument is both categorical and dimensional and is a
solid choice considering that it can be used in both inpatient and outpatient settings, as it can be
provider driven or used in patient self-reporting (Hammash et al., 2012). In a paper reviewing 8
separate depression screening instruments the PHQ and BDI were determined to be superior to
others, however the BDI has already been ruled out for the HF population as it has poor ability to
discern overlap of symptoms (Ceccarini, Manzoni, & Castelnuovo, 2014).
After reviewing the literature, the PHQ-9 appears to be a valid instrument for depression
screening in the inpatient HF population.t. The implementation of depression screening would
apply to all adult HF patients who are admitted to the inpatient setting. There is evidence to
support the use of PHQ-9 screening in the hospitalized HF population; research has found
positive screening to be associated with an increased 4-year all-cause mortality in patients with
systolic heart failure specifically (Deveney, Belnap, Mazumdar, & Rollman, 2016).
The PHQ-9 is practical and valid for the purpose of this study; it has already been chosen
by Norton Healthcare for use in the stroke patient population and is built into the organization’s
electronic medical record (EMR) system; it can be added to the chart of any patient admitted to a
Norton Healthcare facility. Proven to be valid and reliable the PI has chosen to use the PHQ-9
depression screening instrument for the adult inpatient HF population (Hammash et al., 2012).
Purpose
The specific aim of this study is to evaluate the adherence of staff nurses to a new
depression screening protocol for the adult inpatient HF population within NBH ICU 3E and 5W,
following an education intervention. This pilot study aims to identify if there is a correlation
6

between an education intervention and adherence to a screening protocol. The following four
research questions guided this project.
1. What perceptions do providers hold regarding HF and comorbid depression?
2. Are providers knowledgeable about the use of the PHQ-9 depression screening
instrument?
3. Is there a correlation between education about HF with comorbid depression and
depression screening in the critical care setting?

Methods
This project utilized a descriptive quasi-experimental, post-test only evaluation of
adherence to depression screening in the adult ICU inpatient HF population. This study was
designed to measure the adherence rate of NBH ICU staff nurses to newly implemented
depression screening protocol of ICU inpatients, with new or pre-existing diagnosis of HF, using
the PHQ-9 depression screening instrument after an education intervention. Additionally, this
study evaluated staff nursing knowledge and perceptions of depression screening using pre/post
assessment.
Education of the ICU staff nurses about PHQ-9 depression screening within the adult
inpatient HF population as well as use of the PHQ-9 in Epic was be provided in face to face
education sessions, via email and through educational fliers which were posted throughout staff
common areas. A baseline/pre-assessment of knowledge and perception concerning depression
screening (Appendix A) and demographic questionnaire were collected after participant
recruitment and consent. After receiving education, participating nurses were instructed to utilize
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the PHQ-9 for any patient they cared for, in the ICU, who had a new or preexisting diagnosis of
HF.
A retrospective electronic medical record review was conducted, after patient discharge
from the unit and at the end of the study period, to evaluate the number of ICU patients, with a
new or pre-existing diagnosis of HF, who was screened for depression appropriately by
participating nurse. A post-assessment was given to, and completed by, the consented
participating staff nurses at the conclusion of the study period to evaluate for a change in
knowledge and perception of depression screening from baseline measure.
Setting
The Norton Healthcare (NH) system is the largest in the Louisville, KY region and
includes five main hospitals and many urgent care centers offering the residents of Kentucky and
Southern Indiana a full range of medical services. Norton Brownsboro Hospital (NBH) is a 175bed community hospital located in Jefferson County, Kentucky. NBH is one of four hospitals
within the Norton Healthcare systems that serve adult patients. Consisting of 30 beds the ICU at
NBH is a collective force of nurses and managers who work between the units of 3 East and 5
West. The NBH ICU serves patients admitted with neurologic/neurosurgical, cardiac,
pulmonary, medical, surgical and renal critical care needs among others. The study time frame
was from September 27, 2017 through October 30, 2017.
Sample
The study sample consisted of a primary population of providers and a secondary
population of HF patients. The primary population for this study includes NBH ICU staff nurses
who agreed to participate in education sessions and depression screening intervention. Up to
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approximately 76 staff nurses within the NBH ICU were invited to participate. NBH staff nurses
who decline participation were excluded from this study resulting in a total primary population
of 33 providers. All participants are ADN or BSN educated nurses, as this is standing criteria for
employment as a staff nurse in the unit where the study took place. All ethnicities were included.
Agency employed nurses who do not regularly work in NBH ICU were excluded.
The secondary population consists of adult patients, aged 18 years and older, admitted to
the Norton Brownsboro ICU with a new or existing diagnosis of HF during the study period. All
ethnicities are included. This population was to be screened for depression using the PHQ-9
depression screening instrument by participating nurses.
Data Collection
Approvals from the University of Kentucky Institutional Review Board (IRB) and the
Norton Healthcare Office of Research and Administration (NHORA) were obtained prior to
implementation and the collection of data. Patient charts were obtained from the NBH electronic
patient database. Charts were identified using the ICD-10 codes associated with any HF
diagnosis during the study period, this was done by the Norton Healthcare data specialists in the
Health Information Technologies (HIT) department (Table 1). During data collection, patient
records were accessed using the patient medical record numbers (MRN) provided by HIT
specialist. A total of 1,012 patient MRNs were returned, eliminating those patients who were
seen on an outpatient basis reduced the number of MRNs to 157. The primary investigator (PI)
entered each of the remaining 157 medical records to assess if the patient had been in NBH’s
ICU during their hospitalization and if the patient had been under the care of one or more
participating providers. A final yield of 34 MRN’s met study criteria for further review. Of
those, two were omitted as those patients were admitted with a stroke diagnosis and were
9

therefore screened for depression according to the mandatory protocol already in place. A total
of 32 MRN’s were utilized for uses in data analysis.
Provider data for analysis consisted of demographic variables: age, education, years
nursing experience, years ICU nursing experience, gender, ethnicity, and pre/post knowledge and
perception assessments. Data obtained from chart review of the secondary population includes:
number of providers who cared for patient, depression screening completion status, and
documented reason if screening not completed.
Data Analysis
Descriptive statistics, including means, frequency distribution, and SD were used to
describe patients’ demographic characteristics. McNemar’s test was used to test for differences
pre-post for knowledge. Paired t-test was used to differentiate pre-post assessment of perception
of comorbid depression in HF. All analysis was conducted using Statistical Package for the
Social Sciences (SPSS) version 23; a level of P<.05 was used for statistical significance
throughout.
Results
The provider sample demographic characteristics as to age, sex, ethnicity, education
level, and nursing experience can be seen in Table 2. Posttest knowledge remained unchanged
aside from one item. A marked increase of provider knowledge (P =.002) was noted regarding
the time sensitivity of the PHQ-9 to detect depressive symptoms (Table 3). Both pre- and posttest of perception indicates that the participants agree to strongly agree with the three items,
however posttest indicates a significant increase (P=.001, P=.04) in the level of agreement that
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Undetected/Untreated depression is both a problem and has a negative impact on the overall
health of HF patients (Table 4).

Analysis of chart data revealed that among those who were screened, patients were in the
care of an average of 1.6 nurses (SD=2.1, range= 0-6) prior to being screened. Of those who
were not screened, patients were in the care of an average of 3.2 nurses (SD=4.2, range=0-19)
prior to being screened. Depression screening adherence was at 40.6%. However, for those HF
patients who were screened for depression it is noted that the patient was in the care of an
average of 1.6 (SD= 2.1, range 0-6) participating providers prior to being screened. Nonadherence was at 59.4%; for those not screened it is noted that those patients were in the care of
an average of 3.2 (SD= 4.2, range 1-19) participating providers prior to discharge from ICU.

Discussion
This study aimed to determine if a correlation exists between education/knowledge of the
burdens of comorbid depression in the HF population and adherence to a depression screening
protocol for that population. Findings from this study suggest that there is not a correlation
between knowledge and adherence to depression screening for an adult inpatient ICU population.
Despite significant evidence of improved knowledge and increased sensitivity to the
burden of comorbid depression in HF patients, non-adherence to a depression screening protocol
existed even when patients were screened. This is evidenced by the number of participating
providers who cared for the patient prior to the completion of depression screening; out of the
40.6% of the secondary population who were screened for depression, an average of 1.6
participating providers failed to complete depression screening before another provider followed
the study protocol. HF patients who were screened for depression according to the study
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protocol were missed by anywhere from 1 to 6 providers who had volunteered to participate in
this study before a different participating provider followed protocol. Only 1 participating
provider documented a reason for depression screening not being completed, the cited reason
indicated that the patient had been discharged and readmitted as a Hosparus patient. As for the
53.8% of the secondary population who were completely missed by the protocol, they were
missed by an average of 3.2 participating providers, anywhere from 1 to 19. Of note, one HF
patient was under the care of 19 different voluntary participating providers without being
screened for depression OR having a documented reason for depression screening not being
completed.
Prevention is key to improve and preserve population health. The medical consequence
of failing to identify those HF patients at with increased risk of poor outcomes due to comorbid
depression is that providers then miss the opportunity to offer and explore treatment options that
may improve outcomes. It is important to note that the study unit at NBH does have a PHQ-9
depression screening protocol in place for the stroke population, the adherence to depression
screening related to that protocol is 95%; patients who screen positive have results forwarded to
their attending physician who then can plan care accordingly (Lindsey R. Siewert, R.N.,
Neuroscience Clinical Nurse Specialist and stroke coordinator at NBH, personal communication
December 1, 2017). It stands to reason that a HF specific depression screening protocol could be
equally adhered to, if made a standardized requirement.
Limitations
The limitations of this study include small sample of participating nurse
providers, making results less reliable for generalizability. Implementation results may be
different if the conducted with a larger provider population. Pilot period duration was also a
12

limitation. A longer duration may have changed adherence data and/or perceptions of providers.
Implementation of the pilot protocol in a single unit was a limitation. Adherence and perceptions
may have resulted differently had this protocol been implemented across multiple sites.
Additionally, this study it limited by the poor generalizability of results due to the study unit
itself. The study unit was chosen due to its lower acuity level of cardiac patients as compared to
other critical care units within Norton Healthcare, allowing for contact with HF patients prior to
their being lost to discharge.

Recommendations for Future Study
To further assess what steps are necessary to comprehensively identify HF patients with
comorbid depression, a large scale multi-unit, multi-level comparison study that includes
evaluation of factors that contribute to non-adherence of voluntary providers is recommended.
In the course of this study it was found that limited evidence exists concerning the treatment of
depression in the HF population. More research is needed to investigate what care pathways are
most effective in this population. Furthermore, research should be focused according to HF
classifications, as needs and functional ability vary with severity of disease. Investigation of
what steps are currently being taken by physicians and APRNs when depression is identified in
the inpatient HF population.
Conclusion
Recommendations to screen the adult population for depression have been issued by
USPSTF and recommendations to screen for depression the HF population have been found in
international HF guidelines and current research [(Siu, 2016); (SIGN 2016); (Rustad et al.,
2013). The US Guidelines have yet to adopt this measure as a requirement (Yancy et al., 2017).
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Is this because the evidence for the most appropriate and effective treatment is lacking? Or is it
because the resources are not in place to manage the burden of treatment that comes with
identification of the problem?
In the absence of standardized U.S. guidelines that call for depression screening, this
study aimed to determine if a correlation exists between knowledge and sensitivity to the burden
of HF with coexisting depression and adherence to a pilot depression screening protocol.
Despite increased sensitivity in the perception of depression as a burdensome healthcare factor in
the HF population poor adherence to the pilot protocol resulted.
HF is a complex health issue that contributes a massive burden on the healthcare
community (AHA, 2017). An important and pervasive contributor to the poor outcomes
associated with HF has been identified as worsening symptoms of depression (Sherwood,
Andrew, Blumenthal, James & Hinderliter, 2011). We have valid and reliable instruments to
identify depression in HF patients.
The healthcare community continues to search for the most appropriate and agreed upon
treatment for depression in the HF population. There is evidence to suggest that cognitive
behavioral therapy (CBT) targeted towards depression and HF self-care is effective for
depression but not for HF self-care or physical functioning; however other benefits result, such
as reduced anxiety and fatigue, improved social functioning, and better quality of life as related
to health (O'Malley, 2015). Further evidence asserts that there is limited evidence specific to the
treatment of depression in the HF population but supports CBT and pharmacologics such as
selective serotonin reuptake inhibitors (SSRIs), as safe and effective for the reduction of
depressive symptom severity in cardiovascular patients (Rustad et al., 2013).
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In the absence of official US Guideline recommendations that call for screening of all HF
patients for depression, healthcare facilities can incorporate a standardized screening protocol to
identify depression in the adult inpatient HF population so that treatment decisions can be made.
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Table 1. Inclusion List of Heart Failure ICD-10 Codes
Inclusion Criteria List of Heart Failure ICD-10 Codes
ICD-10 Diagnosis Definition
Codes
I11.0
Hypertensive heart disease with heart failure
I13.0
Hypertensive heart and chronic kidney disease with heart failure and stage 1
through stage 4 chronic kidney disease, or unspecified chronic kidney disease
I13.2
Hypertensive heart and chronic kidney disease with heart failure and with stage 5
chronic kidney disease, or end stage renal disease
I50.20 Unspecified systolic (congestive) heart failure
I50.21 Acute systolic (congestive) heart failure
I50.22 Chronic systolic (congestive) heart failure
I50.23 Acute on chronic systolic (congestive) heart failure
I50.30 Unspecified diastolic (congestive) heart failure
I50.31

Acute diastolic (congestive) heart failure

I50.32
I50.33
I50.41

Chronic diastolic (congestive) heart failure
Acute on chronic diastolic (congestive) heart failure
Acute combined systolic (congestive) and diastolic (congestive) heart failure

I50.42
I50.43

Chronic combined systolic (congestive) and diastolic (congestive) heart failure
Acute on chronic combined systolic (congestive) and diastolic (congestive) heart
failure

I50.9
I42.90

Heart failure, unspecified
Cardiomyopathy

Table 2. Nurse Participant Demographics n=33
Age
Education
ADN
BSN
Years experience as a nurse
Years experience as an ICU nurse
Gender
Female
Male
Race
Black or African American
Caucasian
American Indian/ Alaskan Native
Asian
Hispanic

Mean (SD) or n (%)
34.9 (9.7)
6 (18%)
27 (82%)
7.2 (8.7)
6 (8.1)
24 (73%)
9 (27%)
1 (3%)
30 (91%)
0
0
2 (6%)
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Table 3. Pre-post Knowledge Assessment n=33

The PHQ-9 tool is
used to assess for
what condition?
Depression
How do you access
the PHQ-9 tool for
patient assessment?
Flowsheets

The PHQ-9 monitors
for symptoms of
depression that have
been present for: 2
Weeks
Symptoms of
depression have no
effect on selfefficacy or
adherence to
medical treatment.
False

Pre
% correct
100%

Post
% correct
100%

NA

100%

100%

NA

46%

85%

.002

98%

98%

NA

p

Table 4. Pre-post Perception Assessment of Untreated/ Undetected Depression n=33

Is a problem in the
heart failure patient
population
Negatively impacts
the overall health of
individual heart
failure patients
Negatively impacts
medical compliance
of individual heart
failure patients

Pre
Mean (SD)
2.1 (1.1)

Post
Mean (SD)
1.4 (0.7)

.001

1.8 (1.3)

1.4 (0.7)

.04

1.9 (1.3)

1.4 (0.7)

.09
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p

Appendix A

Assessment of Knowledge
1. The PHQ-9 tool is used to assess for what condition?
a. Obstructive sleep apnea
b. Suicide risk
c. Depression
d. AMI risk
2. How do you access the PHQ-9 tool for patient assessment?
a. Navigator
b. Chart Review
c. Results Review
d. Flowsheets
3. The PHQ-9 monitors for symptoms of depression that have been present for:
a. 1-month
b. 1-week
c. 2-months
d. 2-weeks
4. Symptoms of depression have no effect on self-efficacy or adherence to medical
treatment.
a. True
b. False
How strongly do you agree or disagree with each of the following:
1-Strongly agree
2- Agree
3- Neither agree nor disagree
4- Disagree
5- Strongly disagree
Untreated/undetected depression:
a. Is a problem in the heart failure patient population? 1 2 3 4 5
b. Negatively impacts the overall health of individual heart failure patients? 1 2 3 4 5
c. Negatively impacts medical compliance of individual heart failure patients? 1 2 3 4 5
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